Skip to main content
See every side of every news story
Published loading...Updated

Mounjaro becomes India’s top-selling drug as patients shift to GLP-1 injections

Mounjaro becomes India's top-selling drug, with ₹1,256 crore in sales as patients prefer injectable GLP-1 treatments over oral options.

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Hindu Business Line broke the news in Chennai, India on Monday, September 7, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal